Question

In: Anatomy and Physiology

Discuss how our body responds to SARS-Cov-2 infection

Discuss how our body responds to SARS-Cov-2 infection

Solutions

Expert Solution

Body Responses to SARS-CoV-2

- SARS CoV-2 is caused by a positive-sense RNA virus that has got spikes all around its body and affects mainly the upper and lower respiratory tract.

- 80% of the infected individuals only shows very mild or even 'no' symptoms.

- the symptoms showed them like fever, fatigue and dry cough, and even sometimes severe pneumonia.

- The infected individuals would be observed with high levels of cytokines like IL-2, IL-6, IL-7, IP-10, MCP-1, TNF-.

- This increased cytokine level causes acute respiratory distress syndrome, organ failure, or sometimes can lead to a patient's death.

- mostly in the patients, an uncontrolled immune response condition is observed.

- this uncontrolled condition occurred because of the hyperactivation of macrophages and monocytes.

- Thus in turn increases the neutrophil concentration, reactive protein C, and interleukin-6 and decrease T and B lymphocytes concentration.

- The activation of Th17 by the T helper cells causes inflammatory reactions.

- Activation of B lymphocytes causes the formation of antibodies against the virus in order to neutralize them.

- the immunoglobulin (IgG and IgM) levels will be higher in the infected individuals.

- with about 3-6 days of infection, the increased IgM concentration is observed and within 8 days the IgG levels also increase.

- some specialized T cells, B cell, and even NK cell number will be higher.


Related Solutions

COVID-19 is a disease caused by SARS-CoV-2. This coronavirus infection results in an acute respiratory infection...
COVID-19 is a disease caused by SARS-CoV-2. This coronavirus infection results in an acute respiratory infection that can lead to viral pneumonia and end-organ failure. CoV-2 is a RNA virus (single stranded RNA genome) that specifically targets cells in the lungs that express the ACE2 receptor. Answer the three related questions regarding a mucosal immune response to SARS-CoV-2: 1. Which antibody class would you expect to encounter CoV-2 and which T effector T cell would activate B cells? As the...
Explain how SARS-COV-2 replicate?
Explain how SARS-COV-2 replicate?
With all that you know about SARS-CoV-2 and Covid-19, discuss a possible evolutionary scenario for SARS-CoV-2...
With all that you know about SARS-CoV-2 and Covid-19, discuss a possible evolutionary scenario for SARS-CoV-2 , over the next 6 months, 1 year and 5 years. How, if at all, will the virulence/trasmissability of SARS-CoV-2 change and why? A vaccine was developed for Polio, but, so far, not for HIV. Will science develop an effective vaccine against SARS-CoV-2? Why or why not?
Other coronaviruses such as SARS-CoV and MERS-CoV are known suppressors of Type I IFNs. Presumably, SARS-CoV-2...
Other coronaviruses such as SARS-CoV and MERS-CoV are known suppressors of Type I IFNs. Presumably, SARS-CoV-2 employs similar strategies. Explain how SARS-CoV and MERS-CoV may interfere with Type I IFN production and signaling through their receptors.
Design of a Biomaterial using bioluminescence (Nanotheranostic particle or 3D-Scaffold) for the treatment of SARS-Cov-2 infection,...
Design of a Biomaterial using bioluminescence (Nanotheranostic particle or 3D-Scaffold) for the treatment of SARS-Cov-2 infection, which uses monoclonal antibody as a bioactive component for better uptake or adhesion by pulmonary cells.
Research the Internet (using credible sources). How does SARS-CoV-2 attack our respiratory system?
Research the Internet (using credible sources). How does SARS-CoV-2 attack our respiratory system?
Can you identify an innate immune cell that responds to SARS-COV2 infection? What are mechanisms by...
Can you identify an innate immune cell that responds to SARS-COV2 infection? What are mechanisms by which the cell facilitates clearance of the virus?
What portions of our innate defenses does SARS-CoV-2 (or pneumococcal pneumonia) either avoid, overwhelm, or activate....
What portions of our innate defenses does SARS-CoV-2 (or pneumococcal pneumonia) either avoid, overwhelm, or activate. Explain.
Case study: SARS-CoV-2 a) Define the terms R0 and case fatality rate, b) Discuss the factors...
Case study: SARS-CoV-2 a) Define the terms R0 and case fatality rate, b) Discuss the factors that influence the case fatality rate. c) Discuss how SARS-CoV-2 enters human cells, the antigenic target of vaccine approaches and the immune response they aim to induce, and how this would protect against infection.
Policy responses of African States to the SARS-CoV-2 pandemic. Target ( 2 Pages )
Policy responses of African States to the SARS-CoV-2 pandemic. Target ( 2 Pages )
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT